PMID- 25957087 OWN - NLM STAT- MEDLINE DCOM- 20160323 LR - 20150606 IS - 1872-8057 (Electronic) IS - 0303-7207 (Linking) VI - 411 DP - 2015 Aug 15 TI - 9-Demethoxy-medicarpin promotes peak bone mass achievement and has bone conserving effect in ovariectomized mice: Positively regulates osteoblast functions and suppresses osteoclastogenesis. PG - 155-66 LID - S0303-7207(15)00224-5 [pii] LID - 10.1016/j.mce.2015.04.023 [doi] AB - We report a new bone anabolic and anti-catabolic pterocarpan 9-demethoxy-medicarpin (DMM) for the management of postmenopausal osteoporosis. DMM promoted osteoblast functions via activation of P38MAPK/BMP-2 pathway and suppressed osteoclastogenesis in bone marrow cells (BMCs). In calvarial osteoblasts, DMM blocked nuclear factor kappaB (NFkappaB) signaling and inhibited the mRNA levels of pro-inflammatory cytokines. DMM treatment led to increased OPG (osteoprotegrin) and decreased transcript levels of TRAP (tartarate resistant acid phosphatase), RANK (receptor activator of NFkappaB) and RANKL (RANK ligand) in osteoblast-osteoclast co-cultures. Immature female SD rats administered with DMM exhibited increased bone mineral density, bone biomechanical strength, new bone formation and cortical bone parameters. Ovx mice administered with DMM led to significant restoration of trabecular microarchitecture and had reduced formation of osteoclasts and increased formation of osteoprogenitor cells in BMCs. DMM exhibited no uterine estrogenicity. Overall, these results demonstrate the therapeutic potential of DMM for the management of postmenopausal osteoporosis. CI - Copyright (c) 2015 Elsevier Ireland Ltd. All rights reserved. FAU - Goel, Atul AU - Goel A AD - Medicinal & Process Chemistry, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi 110001, India. Electronic address: atul_goel@cdri.res.in. FAU - Raghuvanshi, Ashutosh AU - Raghuvanshi A AD - Medicinal & Process Chemistry, CSIR-Central Drug Research Institute, Lucknow 226031, India. FAU - Kumar, Amit AU - Kumar A AD - Medicinal & Process Chemistry, CSIR-Central Drug Research Institute, Lucknow 226031, India. FAU - Gautam, Abnish AU - Gautam A AD - Endocrinology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India. FAU - Srivastava, Kamini AU - Srivastava K AD - Endocrinology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India. FAU - Kureel, Jyoti AU - Kureel J AD - Endocrinology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India. FAU - Singh, Divya AU - Singh D AD - Endocrinology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150505 PL - Ireland TA - Mol Cell Endocrinol JT - Molecular and cellular endocrinology JID - 7500844 RN - 0 (Bone Density Conservation Agents) RN - 0 (Pterocarpans) RN - 6TX086I6IG (medicarpin) SB - IM MH - Animals MH - Bone Density/*drug effects MH - Bone Density Conservation Agents/*pharmacology/therapeutic use MH - Cell Differentiation/drug effects MH - Female MH - Humans MH - Mice MH - Osteoblasts/cytology/*drug effects MH - Osteoclasts/cytology/*drug effects MH - Osteoporosis, Postmenopausal/drug therapy MH - Ovariectomy MH - Pterocarpans/*pharmacology/therapeutic use MH - Rats MH - Rats, Sprague-Dawley OTO - NOTNLM OT - Bone-anabolics OT - Bone-anticatabolics OT - Demethoxy-medicarpin OT - Osteoporosis OT - Pterocarpans EDAT- 2015/05/10 06:00 MHDA- 2016/03/24 06:00 CRDT- 2015/05/10 06:00 PHST- 2015/01/01 00:00 [received] PHST- 2015/04/11 00:00 [revised] PHST- 2015/04/27 00:00 [accepted] PHST- 2015/05/10 06:00 [entrez] PHST- 2015/05/10 06:00 [pubmed] PHST- 2016/03/24 06:00 [medline] AID - S0303-7207(15)00224-5 [pii] AID - 10.1016/j.mce.2015.04.023 [doi] PST - ppublish SO - Mol Cell Endocrinol. 2015 Aug 15;411:155-66. doi: 10.1016/j.mce.2015.04.023. Epub 2015 May 5.